Navigation Links
What Recession? How Biomedical Device Companies Thrived in a Bad Economy
Date:1/31/2012

NEW YORK, Jan. 31, 2012 /PRNewswire/ -- The biomedical devices industry grew, invested, and prospered from 2007 to 2009, flouting an overwhelming trend that saw many of the world's largest companies collapse during the worst economic climate since the Great Depression. How did they do it? A new analysis of this industry from WTP Advisors, the global tax and business advisory firm, reveals three key traits that helped recession-proof the top independent biomedical device makers around the world, and determines whether or not their success is sustainable over the long-term.

The study is published in the current online edition of the biomedical industry journal MD+DI.

"In short, our study shows that the best of biomedical device makers succeed by making very little, very well, for sale at very high prices," says lead author, Yair Holtzman, director at WTP Advisors and Global Life Sciences practice leader.

The authors looked at 25 of the top independent biomedical device makers worldwide[1] and analyzed their business strategies, financial results, marketing investment, product portfolios, and research and development to better understand what drove growth and profitability in a time of worldwide downturn.  They found three common characteristics shared by the most successful of the 25 firms that appeared to contribute to their growth during the recession, and are still a factor today, including:

  • High Value-Added Manufacturing: Building advanced technology products in developed markets while adding a very high level of value to base costs has and will continue to do well for this sector.  For highly differentiated products sold as customized solutions, the U.S. and Europe have been great places to establish and grow businesses.
  • Increased Marketing Efforts: These companies continued to increase spend on marketing efforts during the Great Recession of the last couple of years (2008-2010).
  • Investment in Research & Development and New Products: The most successful biomedical device companies developed a robust pipeline of new products and R&D capabilities, which allowed them to navigate challenging times successfully. Even during the great recession they were increasing their R&D spend.

However, Holtzman warns, "Despite the unparalleled success of the biomedical device industry from a 10,000 foot view, our close study reveals operational fissures that, if left unchecked could threaten future growth."

For instance, some firms, having grown through acquisition of start-ups and by purchasing of piece parts of organizations now have too many plants and too many labs to be efficient.

Holtzman believes that consolidation will be a key driver facilitating growth over the coming years and that companies should sweep up the collections of purchased parts and turn these businesses into coherent and focused companies in order to achieve maximum efficiency.

In the future, the industry review reveals that the big opportunity for the biomedical device business – one already being grasped by the best in the industry – will be to move beyond the sometimes bumpy revenue stream from selling things, and migrate to a business model focused on selling systems that provide a point of control and differentiation (through software) or that yield sustained revenues from related consumable products used in caring for patients.

"This is the kind of strategy that worked for King Gillette when his business first adopted the razor and blades model, and one that has also worked for IBM as it has migrated from a hardware business to one driven by sustained revenue streams from software and services," Holtzman says.

Going forward, Holtzman concludes, biomedical device companies will need to demonstrate that a particular intervention improves a specific patient outcome and is more cost effective than existing alternative treatments available on the market.

WTP Advisors is a leader in tax and business advisory services for a global marketplace. Our highly skilled professionals equipped with years of industry experience, coupled with our cutting-edge technologies, make substantive and long-term differences to an organization's profitability. WTP Advisors is headquartered in White Plains, N.Y., with offices across the Americas, Asia and Europe.

[1] The organizations that were examined in this analysis include:  Abbott Labs, Alcon, B. Braun, Baxter, Beckman Coulter, Becton, Dickinson, Biomet, Inc., Boston Scientific, C R Bard, Inc., CareFusion, Covidien, Danaher, Fresenius Medical Care, Getinge AB-B, Hospira, Medtronic, Smith & Nephew, Inc., St. Jude Medical, Stryker, Synthes, Terumo, Tornier, Varian Medical, Wright Medical, Technology, and Zimmer Holdings.

 


'/>"/>
SOURCE WTP Advisors
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Crux Biomedicals IVC Filter Receives CE Mark Approval
2. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
3. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
4. Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™"
5. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
6. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
7. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
8. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
9. FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans
10. Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS)
11. Crux Biomedical Names Randy Lindholm Chairman of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):